Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amber M Smith

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Immunity|August 23, 2018
Memory CD8<sup>+</sup> T Cells Use Cell-Intrinsic Lipolysis to Support the Metabolic Programming Necessary for DevelopmentDavid O'Sullivan, Gerritje J W van der Windt, Stanley Ching-Cheng Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
General nature of the STAT3-activated anti-inflammatory responseKarim C El Kasmi, Jeff Holst, Maryaline Coffre, et al.
Nature Immunology|November 4, 2008
Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogensKarim C El Kasmi, Joseph E Qualls, John T Pesce, et al.
Viruses|March 30, 2023
Dissecting Phenotype from Genotype with Clinical Isolates of SARS-CoV-2 First Wave VariantsMariah K Taylor, Evan P Williams, Yi Xue, et al.
Ebiomedicine|May 22, 2022
Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug developmentAditya H Gaur, John C Panetta, Amber M Smith, et al.
The Lancet. Infectious Diseases|April 11, 2020
Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trialAditya H Gaur, James S McCarthy, John C Panetta, et al.
Structure (London, England : 1993)|February 22, 2023
Computational pipeline provides mechanistic understanding of Omicron variant of concern neutralizing engineered ACE2 receptor trapsSoumya G Remesh, Gregory E Merz, Axel F Brilot, et al.
Biorxiv : the Preprint Server for Biology|August 19, 2022
Computational pipeline provides mechanistic understanding of Omicron variant of concern neutralizing engineered ACE2 receptor trapsSoumya G Remesh, Gregory E Merz, Axel F Brilot, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Iterative community-driven development of a SARS-CoV-2 tissue simulatorMichael Getz, Yafei Wang, Gary An, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformationMichael Schoof, Bryan Faust, Reuben A Saunders, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Immunity|August 23, 2018
Memory CD8<sup>+</sup> T Cells Use Cell-Intrinsic Lipolysis to Support the Metabolic Programming Necessary for DevelopmentDavid O'Sullivan, Gerritje J W van der Windt, Stanley Ching-Cheng Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
General nature of the STAT3-activated anti-inflammatory responseKarim C El Kasmi, Jeff Holst, Maryaline Coffre, et al.
Nature Immunology|November 4, 2008
Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogensKarim C El Kasmi, Joseph E Qualls, John T Pesce, et al.
Viruses|March 30, 2023
Dissecting Phenotype from Genotype with Clinical Isolates of SARS-CoV-2 First Wave VariantsMariah K Taylor, Evan P Williams, Yi Xue, et al.
Ebiomedicine|May 22, 2022
Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug developmentAditya H Gaur, John C Panetta, Amber M Smith, et al.
The Lancet. Infectious Diseases|April 11, 2020
Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trialAditya H Gaur, James S McCarthy, John C Panetta, et al.
Structure (London, England : 1993)|February 22, 2023
Computational pipeline provides mechanistic understanding of Omicron variant of concern neutralizing engineered ACE2 receptor trapsSoumya G Remesh, Gregory E Merz, Axel F Brilot, et al.
Biorxiv : the Preprint Server for Biology|August 19, 2022
Computational pipeline provides mechanistic understanding of Omicron variant of concern neutralizing engineered ACE2 receptor trapsSoumya G Remesh, Gregory E Merz, Axel F Brilot, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Iterative community-driven development of a SARS-CoV-2 tissue simulatorMichael Getz, Yafei Wang, Gary An, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformationMichael Schoof, Bryan Faust, Reuben A Saunders, et al.
Pageof 11